Phase 1 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Multiple Sclerosis (MS)
- You are between 21 and 70 years old
- You have some difficulty using your arms or hands due to MS (based on a specific questionnaire score)
- You are able to attend sessions at the study location 3 times per week
- If you are a woman who could become pregnant, you are willing to take a home pregnancy test before starting and before each part of the study, and confirm a negative result within 2 weeks of joining
Who may not be able to join:
- You have had an MS relapse (flare-up) in the past 6 months
- You have an implanted device such as a nerve stimulator or a baclofen pump inside your body
- You have had Botox injections in your arm or hand in the past 6 months
- You are taking a medication called dalfampridine and your dose is not stable during the study period
- You have another neurological condition (such as a history of stroke, brain injury, epilepsy, ALS, spinal cord injury, or certain nerve or brain conditions) that could affect the study results (confirm with trial site)
- You have a serious active mental health condition, such as severe depression, dementia, or alcohol or drug misuse, that could interfere with the treatment
- You have a serious ongoing health condition (such as heart rhythm problems, uncontrolled high blood pressure, cancer, kidney failure, or certain other conditions) that would prevent you from taking part
- You have severe stiffness or tightening of the joints in your hand or arm that could interfere with study activities
- You have very severe muscle stiffness (spasticity) in both sides of your upper arm or hand, as measured by a specific medical scale
- You are currently pregnant or breastfeeding
- In the opinion of the study team, you are not able to fully understand, cooperate with, or safely carry out the study procedures
- You are not able to give your own consent to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sarah Simmons, MD, PhD, University of Washington
Phone: 206-356-6352
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Nine-Hole Peg Test; NeuroQoL Upper Extremity Function; Participant Drop-out rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.